Our evidence standard
Clear about what is known.
Clearer about what is not.
Supported
Selected biomarker changes
Human trials reported changes in triglycerides, some inflammatory and oxidative-stress markers, lipid-metabolism-related gene expression, NRG4, and selected gut bacteria or barrier markers.
Developing
Appetite and satiety outcomes
OEA has a biologically plausible role in peripheral satiety signalling. Direct, consistent human evidence for food-noise reduction remains limited.
Not established
Disease treatment claims
The studies reviewed here do not establish that OEA treats obesity, fatty liver disease, PCOS, stroke, or any other medical condition.